Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.77B | $2.69B | +2.96% |
Cost of Revenue | $363M | $342.6M | +5.95% |
Operating Income | $630.1M | $1.14B | -44.70% |
Net Income | $646.3M | $1.1B | -41.22% |
EPS (Basic) | $2.52 | $4.26 | -40.85% |
EPS (Diluted) | $2.49 | $4.21 | -40.86% |
SG&A Expense | $396.4M | $342.7M | +15.67% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $22.88B | $23.92B | -4.34% |
Current Assets | $10.01B | $13.29B | -24.68% |
Total Liabilities | $6.38B | $5.37B | +18.87% |
Current Liabilities | $3.78B | $3.8B | -0.33% |
Stockholders' Equity | $16.5B | $18.55B | -11.05% |
Cash & Equivalents | $4.67B | $9.16B | -48.96% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $818.9M | $1.31B | -37.33% |
Investing Cash Flow | $-55.8M | $-2.14B | +97.39% |
Financing Cash Flow | $-680.4M | $-357.5M | -90.32% |
Share Buybacks | $426.1M | $131.2M | +224.77% |
D&A | $48.4M | $53.5M | -9.53% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 22.7% | 42.4% | -19.61% |
Net Margin | 23.3% | — | — |
ROE | 3.9% | — | — |
ROA | 2.8% | — | — |
Current Ratio | $2.646 | — | — |
Debt to Equity | $0.387 | — | — |
Other companies in Biotechnology